Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.27.762311

mito-overview: a mitochondrial report software

Abstract

Interpreting mitochondrial DNA variation requires relating allele representation and genomic annotation to the sequencing evidence available for each sample. We developed mito-overview to integrate mitochondrial coverage, candidate allele fractions, genomic annotations and long read co-occurrence in mitochondrial genomic reports. Analysis of a subset of public GM12878 long read data from Vandiver and colleagues Cas9 enrichment study of full-length mitochondrial genomes (SRR18110025) identified 16 candidate variants. Among these candidates, co-occurrence analysis showed that m.8860A>G and m.14831G>A occurred together in all 366 jointly callable query names, demonstrating how mito-overview extends individual allele measurements to quantify shared read support between mitochondrial sites. Analysis of public GM11906 short read data (GSE142741), pooled from three single-cell ATAC-seq libraries, recovered the previously characterized disease-associated m.8344A>G variant in MT-TK at an alternate allele fraction of 72.1% (740 of 1,027 callable observations). The recovered variant identity and MT-TK assignment agree with Lareau and colleagues original study, providing a disease-relevant example of mito-overview combined candidate detection and genomic annotation. We also examined ONT data from blood, fibroblast and muscle of one patient using a separate internal workflow. Heteroplasmy was estimated from alternate allele fractions calculated separately for each tissue. The respective analyses yielded 90, 52 and 60 candidates, with 19 candidate identities shared across all three lists. For these shared candidates, the tissue-specific estimates enabled examination of both variant presence and allele representation across the sampled tissues, illustrating the application of mitochondrial genomic reports to heteroplasmy assessment in disease research. By combining candidate identification with allele measurements, genomic annotations and shared read support, mito-overview enables researchers to examine which variants are observed, their representation within a sample and their co-occurrence with other mitochondrial alleles. These complementary measurements support the selection and characterization of candidate variants for further study in mitochondrial disease research.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gai, X., Ahuja, K., LOPES, E. N.. 2026-10-29. mito-overview: a mitochondrial report software. https://doi.org/10.64898/2026.10.27.762311

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Carrier-Limited Release Risk in Electrospun Nanofibers for Regenerative Endodontics: Constraint Discovery from 25 Formulations

Regenerative endodontics needs an intracanal carrier that keeps disinfecting across a dressing interval that clinicians schedule at one to four weeks, without harming the stem cells that rebuild the pulp. We ask what one completed 25-formulation electrospinning campaign of poly(vinylpyrrolidone) (PVP) fibers carrying metronidazole, ciprofloxacin, minocycline and Ca(OH)2 can decide, and use machine learning for constraint discovery and decision support rather than as a new predictor. After an audit against the source thesis, logistic regression predicts fine-fiber formation at 96% leave-one-out accuracy, but a one-threshold rule does as well, the gain over the 80% majority baseline is not significant (exact McNemar p = 0.125), and accuracy falls to 84% when mixture loading is encoded per component. Diameter models interpolate within formulation families (ridge MAE 193 nm, 95% CI 96 to 317 nm) and fail across them (R^2 < 0). Because the campaign never measured release, we assemble a same-drug, cross-carrier evidence table: 17 bounded metronidazole and ciprofloxacin observations from seven studies, with two-sided censoring. Water-soluble carriers (PVP, PVA) completed release within 80 h (PVP within 8 h); no water-insoluble monolithic carrier reached 90% within its observation window, releasing 1.5 to 50%; both within-study comparisons separate at matched loading; and blend, core-shell and thick-mat architectures released over 3 to 28 days. The PVP mats therefore carry a carrier-limited release risk, not a proven ceiling, and one dissolution experiment can confirm or overturn it. A censoring-aware screen keeps three necessarily and one possibly nondominated formulation, and fixed-budget replays show that uncertainty sampling finds failed formulations sooner, except the one it is confidently wrong about.

bioinformatics↗

CellMethMarker provides an integrated database of human cell- and tissue-type-specific DNA methylation markers

Cell- and tissue-type-specific DNA methylation markers provide epigenetic signatures of cellular identity and are widely used to infer cellular origin from bulk and single-cell methylomes. Existing resources mainly emphasize disease-associated biomarkers, methylome atlases, genomic annotations or RNA-based cell markers, leaving an unmet need for an integrated region-level resource dedicated to such markers. Here we present CellMethMarker (http://gu-zhanglab.hfcas.ac.cn/CellMethMarker), a curated database integrating 347,514 de novo markers derived from uniformly processed whole-genome and reduced-representation bisulfite sequencing datasets, 2,203,507 literature-derived marker records and harmonized metadata for 2,810 samples. CellMethMarker enables cell- and tissue-centered marker retrieval, coordinate-based search, genome-browser visualization, interactive methylation analysis and data download. In an independent single-cell methylome atlas, these markers recover the expected cell-type-associated methylation patterns, and a platform-matched reference built from them lowers the mean deconvolution error from 0.365 to 0.144. CellMethMarker therefore links region-level DNA methylation variation to cellular identity and supports methylome-based cell-type annotation and deconvolution.

bioinformatics↗

IG-28 enables identification and quantification of high-confidence isoforms from large bulk and single-cell full-length cDNA datasets

The technology to sequence full-length transcriptomes from bulk and single-cell samples has rapidly advanced. As a result, full-length cDNA datasets now reach billions of reads in size which is beyond the capability of most established isoform identification tools. Here, we introduce IG-28 which addresses this challenge with its capability to process and analyze large fl-cDNA datasets fast and using minimal computational resources. In contrast to its predecessor Mandalorion, IG-28 is not limited to bulk fl-cDNA but is capable of parsing, processing, and analyzing single-cell fl-cDNA datasets. It does so in a lightweight, flexible manner, integrating seamlessly with established scRNA-seq analysis workflows. We benchmarked IG-28 against a variety of established and new isoform identification tools using several bulk and a complex single-cell fl-cDNA dataset and found that IG-28 consistently outperformed the other tools by identifying high-confidence public isoforms.

bioinformatics↗